FDA’s ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience

FDA’s Center for Drug Evaluation and Research (CDER) recently accepted a new submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. This submission is the first artificial intelligence-based and digital health technology-based project and the first pro